Erwin Surmann

1.2k citations

19 papers · 876 indexed · h-index 15

Impact in

Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
Cognitive Neuroscience top 10%
- Sleep and Wakefulness Research
- Autism Spectrum Disorder Research

Papers in ⓘ

Neurology 18
- Parkinson's Disease Mechanisms and Treatments 18
- Neurological disorders and treatments 11
- Botulinum Toxin and Related Neurological Disorders 10
- Parkinson's Disease and Spinal Disorders 1
Physical Therapy, Sports Therapy and Rehabilitation 1
- Balance, Gait, and Falls Prevention 1

Co-authors: Babak Boroojerdi (10 shared papers)К. Ray Chaudhuri (7 shared papers)Claudia Trenkwalder (5 shared papers)L. Ghys (5 shared papers)John Whitesides (5 shared papers)Lars Bauer (6 shared papers)Werner Poewe (2 shared papers)Jan Kassubek (2 shared papers)
Journals: Parkinsonism & Related Disorders (6 papers)Journal of Neural Transmission (2 papers)BMC Neurology (2 papers)Neurology (2 papers)Journal of Parkinson s Disease (1 paper)
Partner nations: Germany United States Belgium

In The Last Decade

Erwin Surmann

19 papers receiving 858 citations

Peers

Countries citing papers authored by Erwin Surmann

Since Specialization

Citations

This map shows the geographic impact of Erwin Surmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Surmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Surmann more than expected).

Fields of papers citing papers by Erwin Surmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin Surmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Surmann. The network helps show where Erwin Surmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Erwin Surmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erwin Surmann Line = papers co-authored together Erwin Surmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) Movement Disorders ·Claudia Trenkwalder, Bryan Kies, Monika Rudzińska, Jennifer Fine, Janos Nikl, Krystyna Honczarenko, Péter Diószeghy, D. Hill, Tim Anderson, Vilho V. Myllylä, Jan Kassubek, M. Steiger, Marco Zucconi, Eduardo Tolosa, Werner Poewe, Erwin Surmann, John Whitesides, Babak Boroojerdi, К. Ray Chaudhuri, Type Diabetes TrialNet Study Group	2010	326
2	Rotigotine and specific non-motor symptoms of Parkinson's disease: Post hoc analysis of RECOVER Parkinsonism & Related Disorders ·К. Ray Chaudhuri, Pablo Martínez‐Martín, Angelo Antonini, Richard G. Brown, Joseph H. Friedman, Marco Onofrj, Erwin Surmann, L. Ghys, Claudia Trenkwalder	2013	108
3	A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain The Journal of Clinical Pharmacology ·Olivier Rascol, Theresa Zesiewicz, К. Ray Chaudhuri, Mahnaz Asgharnejad, Erwin Surmann, Elisabeth Dohin, Sigrid Nilius, Lars Bauer	2015	80
4	Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hocanalysis of the RECOVER study BMC Neurology ·Jan Kassubek, К. Ray Chaudhuri, Theresa Zesiewicz, Erwin Surmann, Babak Boroojerdi, Kimberly Moran, L. Ghys, Claudia Trenkwalder	2014	48
5	Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease BMC Neurology ·Robert A. Hauser, Jarosław Sławek, Paolo Barone, Elisabeth Dohin, Erwin Surmann, Mahnaz Asgharnejad, Lars Bauer	2016	46
6	A Randomized Study of Rotigotine Dose Response on ‘Off’ Time in Advanced Parkinson's Disease Journal of Parkinson s Disease ·Anthony P. Nicholas, Rupam Borgohain, Pedro Chaná, Erwin Surmann, Emily L. Thompson, Lars Bauer, John Whitesides, Lawrence Elmer	2014	36
7	Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study Parkinsonism & Related Disorders ·Lawrence Elmer, Erwin Surmann, Babak Boroojerdi, Joseph Jankovic	2012	36
8	Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER Journal of Neural Transmission ·Peter A. LeWitt, Babak Boroojerdi, Erwin Surmann, Werner Poewe	2012	36
9	Effect of rotigotine on sleep and quality of life in Parkinson's disease patients:post hocanalysis of RECOVER patients who were symptomatic at baseline Expert Opinion on Pharmacotherapy ·L. Ghys, Erwin Surmann, John Whitesides, Babak Boroojerdi	2011	33
10	The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson’s disease Journal of Neural Transmission ·Nir Giladi, Babak Boroojerdi, Erwin Surmann	2013	28
11	Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study Parkinsonism & Related Disorders ·Zhenxin Zhang, Huifang Shang, Xingyue Hu, Shengdi Chen, Zhongxin Zhao, Xinlu Du, Erwin Surmann, Lars Bauer, Mahnaz Asgharnejad	2016	23
12	Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease Parkinsonism & Related Disorders ·Nir Giladi, L. Ghys, Erwin Surmann, Babak Boroojerdi, Joseph Jankovic	2014	21
13	Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study Parkinsonism & Related Disorders ·Zhenxin Zhang, Chun‐Feng Liu, Enxiang Tao, Ming Shao, Yiming Liu, Jian Wang, Mahnaz Asgharnejad, Haibo Xue, Erwin Surmann, Lars Bauer	2017	18
14	Associations between Severity of Motor Function and Nonmotor Symptoms in Parkinson's Disease: A Post Hoc Analysis of the RECOVER Study European Neurology ·Todd J. Swick, Joseph H. Friedman, К. Ray Chaudhuri, Erwin Surmann, Babak Boroojerdi, Kimberly Moran, L. Ghys, Claudia Trenkwalder	2014	14
15	Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: Results from a 1-year, open-label extension of the RECOVER study Research Portal (King's College London) ·Claudia Trenkwalder, Bryan Kies, Péter Diószeghy, D. Hill, Erwin Surmann, Babak Boroojerdi, John Whitesides, К. Ray Chaudhuri	2012	14
16	Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects Clinical Therapeutics ·Yun Liu, Brian Tomlinson, Guo Ji-yuan, Mahnaz Asgharnejad, Lars Bauer, Erwin Surmann, Xiaojuan Guo, Jan‐Peer Elshoff	2018	3
17	Lacosamide Has No Effect on the Enzymatic Activity of CYP3A4 (P01.076) Neurology ·Willi Cawello, Erwin Surmann, J. Waitzinger	2012	3
18	P2.170 Effect of rotigotine on control of early morning motor function and sleep quality in subjects with idiopathic Parkinson's disease Parkinsonism & Related Disorders ·C. Trenkwalder, К. Ray Chaudhuri, Tim Anderson, Jennifer Fine, D. Hill, Bryan Kies, Monika Rudzińska, Erwin Surmann, John Whitesides, Babak Boroojerdi	2009	2
19	Rotigotine Transdermal System Improves Neuropsychiatric Features (Apathy, Anhedonia, Anxiety, and Depression) and Fatigue in Patients with Parkinson's Disease: A Post-Hoc Analysis of Five Double-Blind Placebo-Controlled Studies (P06.088) Neurology ·Robert A. Hauser, Paul A. Nausieda, Erwin Surmann, K. Moran, Paolo Barone	2012	1

About Erwin Surmann

Erwin Surmann is a scholar working on Neurology, Physical Therapy, Sports Therapy and Rehabilitation, Psychiatry and Mental health, Pharmaceutical Science and Epidemiology, having authored 19 papers that have together received 876 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (11 papers), Botulinum Toxin and Related Neurological Disorders (10 papers), Restless Legs Syndrome Research (5 papers), Attention Deficit Hyperactivity Disorder (2 papers), Parkinson's Disease and Spinal Disorders (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Balance, Gait, and Falls Prevention (1 paper). The work is most often cited by research in Neurology (818 citations), Cognitive Neuroscience (200 citations), Epidemiology (244 citations), Cellular and Molecular Neuroscience (108 citations) and Psychiatry and Mental health (87 citations). Erwin Surmann has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Babak Boroojerdi, К. Ray Chaudhuri, Claudia Trenkwalder, L. Ghys, John Whitesides, Lars Bauer, Werner Poewe, Jan Kassubek, Mahnaz Asgharnejad and Péter Diószeghy. Their work appears in journals such as Parkinsonism & Related Disorders, Journal of Neural Transmission, BMC Neurology, Neurology and Journal of Parkinson s Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact